by David Kent | Feb 9, 2015
> This article is the second in a series about the human capital created by the Network of Centre of Excellence known as the Stem Cell Network (SCN), which was created in 2001, will wind down the majority of it’s activities this year. The first article focused on...
by David Kent | Nov 10, 2010
One of the most memorable moments of my PhD training was at a 2006 Keystone conference where Shinya Yamanaka presented a little something called Pluripotency and Nuclear Reprogramming. He carefully presented the transcription factor screen that would culminate in the...
by Stem Cell Network | Jul 6, 2010
by Tania Bubela Increasingly, commercialization is a key requirement for securing project funding and support for scientific research. The field of stem cell research is no exception. But does this emphasis on commercialization, which necessarily involves issues of...
Comments